Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02540356
Title Phase 1/2a Two-Arm Dose-Escalation Study of BAX69 in Subjects With Malignant Ascites of Ovarian Cancer
Recruitment Terminated
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Baxalta US Inc
Indications

ovary epithelial cancer

Therapies

Imalumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.